FWP
EXAS

Forefront Wealth Partners’s Exact Sciences EXAS Stock Holding History

Forefront Wealth Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,693
Closed -$208K – 195
2025
Q2 		$208K Buy
+3,693
New +$188K 0.14% 97
2025
Q1 		– Sell
-3,693
Closed -$208K – 132
2024
Q4 		$208K Buy
+3,693
New +$230K 0.15% 90

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Forefront Wealth Partners's EXAS Position: Q3 2025 in Review

Forefront Wealth Partners sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 3,693 shares — an estimated $208K sold.

Forefront Wealth Partners first reported a position in EXAS in Q4 2024 and held it in 2 quarters. The position peaked at $208K in Q2 2025. 567 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • Forefront Wealth Partners reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
  • Forefront Wealth Partners sold 3,693 Exact Sciences shares in Q3 2025, an estimated $208K.
  • Forefront Wealth Partners first reported a position in Exact Sciences in Q4 2024 and held it in 2 quarters.
  • Forefront Wealth Partners's Exact Sciences position peaked at $208K in Q2 2025.
  • 567 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on Forefront Wealth Partners's 13F filing for Q3 2025, filed 20 Oct 2025.